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Abstract
Background:  The RNA-binding protein Hfq is involved in stress and virulence of several
pathogens, probably due to its role as mediator in small RNA (sRNA)-mRNA interactions. In this
study, we investigate the function of Hfq in the Gram-positive pathogen Staphylococcus aureus, by
constructing hfq null mutant derivatives.
Results: We report that unexpectedly, in S. aureus, Hfq does not seem to play a crucial role in
stress response, RNAIII or spa mRNA quantity and exoprotein expression, as tested in three
virulent genetic backgrounds. Moreover, a global analysis of the RN6390 hfq mutant, which tests ~
2000 phenotypes, supports our results concerning the non-implication of Hfq in stress response,
and shows that Hfq is also not involved in resistance to several chemical agents and antibiotics and
does not seem to be implicated in metabolic pathways.
Conclusion: Our data suggest that although sRNA-mRNA interactions in S. aureus are decisive
for gene expression regulation, they do not require the RNA-chaperone protein Hfq. These
interactions possibly require an RNA-chaperone protein other than Hfq, which remains to be
found.
Background
The small RNA-binding protein Hfq was first identified in
Escherichia coli as a required factor for replication of phage
Qβ RNA [1]. In E. coli, Hfq is a global regulator that mod-
ulates the stability, translation and polyadenylation of
numerous mRNAs (for review, see [2]). It is proposed that
Hfq acts as a RNA chaperone protein by mediating inter-
actions between many regulatory small RNAs (sRNAs)
and their mRNAs targets (for review, see [2,3]). Inactiva-
tion of the hfq gene in E. coli results in lower growth and
sensitivity to various environmental stresses [4,5].
Genome analyses show that Hfq-like proteins are con-
served in many (but not all) Gram-negative and -positive
bacteria [6]. Hfq is involved in stress response and/or vir-
ulence of several Gram-negative pathogens (Vibrio chol-
erae, Brucella abortus,  Yersinia enterocolitica, Pseudomonas
aeruginosa, Shigella flexneri, Salmonella enterica [7-13] and
the Gram-positive pathogen, Listeria monocytogenes [14].
Staphylococcus aureus is a Gram-positive pathogen respon-
sible for a wide variety of human infections, ranging from
superficial skin and wound infections to deep abscesses
(endocarditis and meningitis), septicemia, or toxin-asso-
ciated syndromes (e.g. food poisoning and toxic shock
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syndrome) [15]. S. aureus is also a leading cause of hospi-
tal and community-acquired infections whose treatment
is becoming increasingly difficult due to the emergence of
multiple antibiotic resistance determinants [16]. The type
of infection caused by S. aureus depends on virulence fac-
tors and stress response pathways present in infectious
strains, and reflects the coordinated action of numerous
regulators (for review, see [17]). The best-characterized
regulator of virulence gene expression is the agr (accessory
gene regulator) quorum sensing system (for review, see
[17]), which comprises two divergent transcripts, RNAII
and RNAIII. The small RNAIII transcript (514 pb) is a key
regulator that modulates production of S. aureus extracel-
lular proteins at the transcriptional and post-transcrip-
tional level (for review, see [17]).
S. aureus encodes one Hfq-like protein (8.9 kDa), whose
structure has been described [18]. Under in vitro condi-
tions, it specifically binds RNAIII and spa  mRNA [19].
More recent studies revealed the expression of other regu-
latory sRNAs among S. aureus infectious strains [20-22],
which may be involved in the regulation of virulence.
These observations suggest that RNA-RNA interactions are
decisive for virulence regulation in S. aureus, while the
role of Hfq in these interactions remains to be elucidated.
In this study, we constructed hfq derivatives in three S.
aureus backgrounds that differ in their virulence capacities
(RN6390, COL and Newman; [23]), and compared them
to their respective WT strains, in order to determine the
Hfq function(s). In the experimental conditions and the
genetic backgrounds tested, Hfq does not display any
detectable role in stress tolerance, RNA stability or exopro-
tein expression. To provide a more complete analysis of
the  hfq  associated phenotypes, we also compared the
RN6390 WT and hfq mutant strains using the Phenotype
Microarray (PM) Technology, which tests ~ 2000 pheno-
types simultaneously (including utilization of several
sources of carbon, nitrogen, phosphate and sulfur, and
sensitivity to different stresses and chemical agents).
Based on our results, we can postulate that in S. aureus,
RNA-RNA interactions do probably not require the
involvement of RNA chaperone proteins, or that at least a
protein other than Hfq, as yet unidentified, is responsible
for the modulation of RNA interactions.
Results and discussion
Inactivation and expression of hfq in S. aureus
We first constructed an hfq mutant in the S. aureus aviru-
lent strain RN4220, in which the region corresponding to
the hfq  ORF was replaced by a cassette conferring Cm
resistance (see Methods and Fig. 1A). Gene inactivation
was verified by Southern blot (data not shown) and the
hfq mutation was then transferred by phage transduction
into three virulent strains that differ in their virulence reg-
ulation pathways, RN6390, Newman and COL. Gene
transfer was confirmed by PCR and RT-PCR (Fig. 1B).
In E. coli, Hfq is one of the most abundant intracellular
proteins, whose level in exponential growth phase is
reportedly around 30,000 to 60,000 molecules per cell
[24]. Hfq levels further increase during the transition to
stationary phase [25]. These data suggest that Hfq likely
plays a crucial role in controlling expression of numerous
growth-related genes. In view of the described properties
of Hfq, we asked whether hfq expression levels in S. aureus
were as high as in E. coli. We first followed hfq expression
during bacterial growth in BHI medium, by northern blot
experiments, using an hfq-specific fragment as probe. No
transcript corresponding to hfq  mRNA was detected in
RN6390, Newman or COL WT backgrounds (from total
RNAs extracted from both exponential and stationary
phase cultures; data not shown). In these experiments, an
E. coli hfq strain containing a plasmid carrying the S.
aureus hfq gene under control of a tetracycline inducible
promoter system was used as positive control of hfq
mRNA expression. We then compared hfq  expression
using RT-PCR, which is a more sensitive detection method
than northern blotting. Steady state levels obtained from
RN6390 WT and hfq post-exponential RNA extracts are
represented on Figure 1B. A band corresponding in size to
the hfq amplicon (which is comparable in size to the frag-
ment amplified from chromosomal DNA) was detected in
the WT profile, suggesting that hfq  is expressed in S.
aureus. As expected, no amplification from both hfq
mutant strain chromosomal DNA (not shown) and
cDNAs (Fig. 1B) was observed, which confirms the hfq
ORF deletion. Positive amplification from cDNAs of the
RN6390 hfq strain was visualized with PCR using spa spe-
cific primers, confirming the quality of these extracts (Fig.
1B). Similar results were obtained with RT-PCR experi-
ments realized with Newman strain.
These results indicate that hfq gene is expressed in S. aureus
in the experimental conditions tested but at a very low
level, as no transcript could be visualized by northern blot
experiments. In view of these data, we speculate that Hfq
protein is probably less abundant in S. aureus than in E.
coli.
hfq inactivation has no effects on growth and stress 
resistance
We first compared growth of hfq mutants of RN6390, COL
and Newman, with their respective WT strains in aerated
BHI rich medium or in aerated RPMI synthetic medium at
37°C. No growth differences were noticed in any of the
genetic backgrounds tested (data not shown) in either
media. As Hfq is reportedly involved in stress tolerance in
many pathogens [8,10,14], we also tested the ability of
staphylococcal hfq mutants to resist to several environ-BMC Microbiology 2007, 7:10 http://www.biomedcentral.com/1471-2180/7/10
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mental stresses: Under osmotic (NaCl), oxidative stress
(H2O2) or heat-shock (44°C) conditions, the hfq mutant
grew as well as the WT strain in all genetic backgrounds
(data not shown). In L. monocytogenes, the contribution of
Hfq in stress response depends on the alternative sigma
factor σB pathway, as σB controls hfq stress-inducible tran-
scription [14]. In S. aureus, Hfq does not seem to be impli-
cated in stress resistance, regardless of the presence or
absence of the σB  pathway, as the same results were
obtained in both σB pathway functional (COL, Newman)
and defective (RN6390) strains.
Hfq does not affect RNAIII or spa mRNA quantity in vivo
In vitro studies showed that Hfq specifically binds the spa
mRNA regulatory region, and more tightly, RNAIII [19].
spa encodes the Staphylococcal protein A (Spa), a major
surface protein. Its expression is known to be repressed by
RNAIII at the transcriptional level by an undetermined
mechanism, but additional studies have shown that
RNAIII also inhibits spa expression by affecting its transla-
tion and stability [19]. To elucidate the involvement of
Hfq in the stability of RNAIII and spa mRNA in vivo, we
compared their steady state levels in WT and hfq mutant
strains. No significant differences were observed in RNAIII
expression in the hfq mutant, compared to the WT strain,
whether in the RN6390 or Newman context (Fig. 2A).
When we compared spa  RNA transcript profiles in
RN6390, Newman and COL backgrounds, no differences
between Δhfq and WT were detected (Fig. 2B). Variation of
spa  mRNA expression visualized between strain back-
grounds reflects differences in virulence regulatory path-
ways, as previously described [23]. Amounts of protein A
were also analysed in staphylococcal strains by western
blot experiments [26] using a monoclonal anti-protein A
antibody (Sigma, Saint Louis, MO, USA); again no differ-
ences were observed (data not shown). The results
described above show that Hfq does not affect the quanti-
ties of RNAIII or of spa mRNA in vivo. In view of these
observations, we speculate that in the natural context of
the bacterium, Hfq does not contribute to the quantities
of RNAIII and spa mRNA and likely has no effect on the
formation of the RNAIII-spa mRNA complex. This is rele-
vant to previous in vitro results showing that increasing
concentrations of Hfq have no effect on the formation of
RNAIII-spa mRNA complex [19].
Hfq does not affect exoprotein expression profiles
S. aureus secretes numerous virulence factors, which are
mainly produced during the post-exponential phase, and
whose expression involves the coordination of many reg-
ulators, including agr RNAIII (for review, see [17]). To test
the possible role of Hfq in the production of secreted vir-
ulence factors, we compared exoprotein profiles in
RN6390, Newman, and COL WT strains and their Δhfq
derivatives. No differences were observed in the various
genetic backgrounds tested (data not shown). Hemolysins
and proteases are major secreted virulence factors in some
S. aureus virulent strains, such as RN6390. To test the
effect of Hfq on production of those secreted enzymes, we
compared hemolytic and proteolytic activities in RN6390
and Newman WT and hfq mutant strains. Stationary cul-
tures were streaked onto BHI medium containing rabbit
blood (which reveals α-hemolytic activity), sheep blood
(corresponding to β-hemolytic activity) and horse blood
Inactivation of hfq in S. aureus (1A) and expression of hfq in S.  aureus RN6390 (1B) Figure 1
Inactivation of hfq in S. aureus (1A) and expression of 
hfq in S. aureus RN6390 (1B). The complete hfq ORF is 
removed and replaced by the cat gene (1A). Genes directly 
up-(mia) and downstream (gpxA1) of hfq are shown, and 
primers used for RT-PCR experiments are indicated by 
arrows. Positions of ORFs related to the N315 annotated 
genome are respectively: mia (13022047-1302982); hfq 
(1302997-1303230), gpxA1 (c1303928-1303452). Total RNAs 
from post-exponential growth phase cultures of RN6390 
WT and hfq mutant strains were first retro-transcribed using 
random hexamer primers. PCR amplification specific to the 
hfq ORF was realized from the cDNAs, obtained from ran-
dom retro-transcription (RT) (1B). Chromosomal DNA of 
WT (WT chrom. DNA) was used as positive control of PCR 
amplification. PCR amplification of the spa gene was also used 
as a positive control of cDNA quality from the RN6390 hfq 
strain. Negative controls of RT-PCR reactions were also 
shown (neg. ctl).
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(δ-hemolytic activity), or onto NB medium containing
skimmed milk (to reveal proteolytic activities). No differ-
ences were observed in halos corresponding to the differ-
ent enzymatic activities in the two genetic backgrounds
tested (data not shown), which suggests that the lack of
Hfq does not affect production of either hemolysins or
secreted proteases.
Altogether, these results suggest that deletion of hfq does
not affect exoprotein expression profiles. It is thus likely
that Hfq is not decisive for the production of secreted vir-
ulence factors.
PM analysis of RN6390 hfq mutant
PM assay is a relatively new technology in which ~ 2000
phenotypes are tested simultaneously, and has already
been used for comparative analysis between strains in sev-
eral bacterial species [27-29]. Strains are grown in micro-
titer plate, each well containing different media. This
technology may help to determine gene functions. Respi-
ration is used in PM as an indication of bacterial growth,
and was compared between strains in media containing
different sources of carbon (PM1 to PM2), nitrogen (PM3
and PM6 to PM8), phosphorus and sulfur (PM4), nutri-
ents or cofactors (PM5), or in the presence of different
stresses or chemical agents (PM9 to PM20). Consensus
PM results of comparative analysis of RN6390 WT and hfq
mutant strains are shown on Figure 3. Additional file 1
indicates values of phenotypes gained or lost. Briefly,
slight or no differences between strains were observed
under any metabolic conditions, and differences in sensi-
tivity to chemical agents observed could not be repro-
duced by independent experimentation.
Metabolism tests (PM1 toPM8), performed in a synthetic
medium, showed negative differences for utilization of
several amino acids or dipeptides as nitrogen source (PM3
and PM6 to PM8); although the signal decreases were very
weak. These data seemed to suggest that the hfq mutant
strain could be defective for nitrogen metabolism. To test
this hypothesis, we compared growth of RN6390 WT and
hfq mutant strains in a synthetic complete medium or in a
synthetic minimal medium (containing the essential
amino acids for auxotrophy, glutamate and leucine; Elise
Durant, INRA, personal communication) with or without
several nitrogen sources, including different combina-
tions of amino acids (including glutamate and/or aspar-
tate) as used in the PM assay. No differences in growth
were observed between the two strains (data not shown),
suggesting that the hfq  mutant uses different nitrogen
sources as well as the WT strain. The weak differences
detected by PM analysis (PM3, PM6 to PM8) may reflect
the use in PM of a standard chemically minimal medium
that lacks the essential amino acids, where only residual
growth of both strains occurred. In this case, it is likely
that phenotypes observed result from residual respiration
of surviving bacteria in the medium and not from real
bacterial growth.
Stress or chemical agent sensitivity PM tests (PM9 to
PM20) were performed in rich medium, similar to LB.
Essentially no differences were observed in osmotic
(PM9) and pH (PM10) stress panels between the RN6390
WT and hfq  mutant strains (Fig. 3), which confirmed
some results obtained by conventional stress tests (see
above). Positive or negative differences were observed for
some chemical agents or antibiotics (PM11 to PM20; see
Fig. 3, and Additional file 1) but signals were weak (see
Additional file 1). The only real signal concerned Cm
resistance of the hfq mutant, a consequence of the strain
construction (PM11, F3-4 and PM 14, F4, and derivative
thiamphenicol, PM18, A10-12). We compared sensitivity
of some chemical agents or antibiotics that gave negative
responses (cobalt chloride, PM13, G3; cefotaxime, PM16,
A3-4), or positive signals (domiphen bromide, PM15, D6;
dodine, PM20, E7) on MH broth by measuring the MIC or
on agar plates using disk-specific antibiotics. Again, no
Northern blot analysis of RNAIII (2A) or spa mRNA (2B)  expression in S. aureus WT and Δhfq strains Figure 2
Northern blot analysis of RNAIII (2A) or spa mRNA 
(2B) expression in S. aureus WT and Δhfq strains. 
Total RNA was extracted from post-exponential phase cul-
tures of RN6390, Newman and COL, WT and Δhfq strains. 
15 μg of total RNA of RN6390 and Newman strains were 
analysed by northern blot, using an RNAIII-specific probe 
(2A). Total RNA from RN6390, Newman and COL strains 
was also compared for spa mRNA expression, using a spa-
specific probe (2B). Results from three independent experi-
ments were identical.
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significant differences were observed between WT and hfq
mutant strains (data not shown).
This comparative analysis showed that among ~ 2000
phenotypes, essentially no reproducible phenotypic dif-
ferences between S. aureus RN6390 WT and its hfq deriva-
tive mutant were detected. For metabolic tests, the few
phenotypes that were noted likely have no physiological
significance, and may result from the poor growth of both
strains. We thus conclude that Hfq has no role on stress
response and on chemical agent sensitivity and probably
no impact on metabolic pathways in S. aureus.
Conclusion
In this study, we tried to elucidate the roles of the RNA-
binding protein Hfq in S. aureus cell physiology and regu-
lation. Our results indicate that Hfq does not seem to con-
tribute to the adaptation to stress responses, RNAIII or spa
mRNA levels, or to general exoprotein production in S.
aureus. Some of these data have been recently suggested
[30]. A more general approach, which tests ~ 2000 pheno-
types simultaneously confirmed our observations (e.g.,
no implication of Hfq in stress sensitivity) and also
showed that Hfq has likely no impact on metabolic path-
ways or on resistance to different chemical agents or anti-
biotics. Nevertheless, it remains possible that Hfq has a
role in environmental conditions that differ from those
tested; for example, those encountered to proliferate
inside the host during the infection process. We compared
growth in rabbit serum between a wild type and its hfq
derivative mutant, in the three different genetic contexts;
no differences were observed (data not shown). This
result suggests that Hfq may not be crucial for survival
inside the host.
In E. coli, Hfq contributes to interactions between regula-
tory sRNAs and their mRNA targets (for review, see [2]). It
also forms a ribonucleoprotein complex with RNase E
that affects mRNAs turnover [31]. Staphylococcal genome
analyses indicate the lack of an RNase E-like protein. In
Bacillus subtilis, RNases J1 and J2 have functional homolo-
gies with RNase E but no sequence similarity [32,33];
PM comparative analysis of RN6390 WT and hfq strains Figure 3
PM comparative analysis of RN6390 WT and hfq strains. The WT and the hfq mutant were subject to PM analysis of ~ 
2000 phenotypes. Incubation and time course curves for respiration (tetrazolium color formation) in specific conditions were 
generated with Omnilog-PM software (see for more details [42]). The PM kinetics shows consensus data comparing the 
RN6390 hfq mutant (green) to its respective WT strain (red). Red indicates a stronger response by the parental strain and 
green indicates a stronger response by the hfq mutant. When the two strains have equivalent metabolism or sensitivity to a 
stress or chemical agent, the red and green kinetic graphs overlap and are yellow. Boxes surrounding a specific condition indi-
cate a significant difference in response. Values of gain or loss of phenotypes are in Table 1 of supplementary data.BMC Microbiology 2007, 7:10 http://www.biomedcentral.com/1471-2180/7/10
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homolog of these RNases are present in S. aureus. How-
ever, it has never been demonstrated that RNases J1 and J2
functions are dependant of Hfq. Although RNA-RNA
interactions appear to be decisive for regulatory pathways
in S. aureus, regulation mechanisms are likely to occur
independently of Hfq and RNase E.
Searches for Hfq conservation through bacterial species
have shown that Hfq homologs are absent in several low
GC Gram-positive bacteria, such as Lactococcus lactis, Strep-
tococcus pneumoniae, and Streptococcus pyogenes [6]. In Bor-
relia burgdoferi, genome analyses reveal the lack of both
Hfq and RNase E proteins [34]. We propose that in S.
aureus, under conditions known to involve Hfq in other
bacteria, RNA-RNA interactions do not require Hfq. An as
yet uncharacterized RNA-chaperone protein might be
responsible for the modulation of RNA interactions in
this bacterium. Database searches in S. aureus genomes for
Sm-like domains, which are characteristic of RNA-binding
protein like Hfq, reveal no other candidates than Hfq. If S.
aureus sRNAs are important for mRNA turnover, we sug-
gest the existence of alternative mechanism that substitute
for Hfq and RNase E that remains to be discovered.
Methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. S. aureus strains were routinely grown in BHI
medium with aeration at 37°C, or at 30°C for the
RN4220 strain harboring the thermosensitive plasmid.
Defined synthetic medium used for staphylococcal
growth was either RPMI medium 1640 (Gibco-Invitrogen,
Eugene, USA) or as published [35]. E. coli DH5αZ1 [36],
which was used for cloning experiments, was grown in LB
broth at 37°C. Antibiotics were added to media as needed
at the following concentrations: Cm, 5 μg/ml for S. aureus
and 10 μg/ml for E. coli; Ery, 2 μg/ml for S. aureus and
Amp, 100 μg/ml for E. coli. X-Gal was added as needed to
BHI plates at a final concentration of 150 μg/ml.
For stress studies, staphylococcal cultures were prepared
as follows: serial dilutions of exponential cultures were
spotted on BHI plates containing or not an osmotic stress
agent (NaCl, 0.5 to 2 M) or an oxidative stress agent
(H2O2, 1 to 2 mM), and incubated at 37°C for 24 h.
Growth at high temperature was examined by plating cells
on BHI medium and incubating at 44°C for 24 h.
Table 1: Strains and plasmids used in this study.
Key features Reference
Strains
E. coli DH5αZ1 Δ(argF-lac)169 ϕ80ΔlacZ58(M15) glnV44 (AS) 
rfbD1 gyrA96 (NalR) recA1 endA1 spoT1 thi-1 
hsdR17 Z1(lacR tetR SpR)
[36]
S. aureus RN4220 Avirulent mutant of NCTC 8325-4 that accepts 
foreign DNA
[43]
S. aureus RN6390 Laboratory virulent strain derived from NCTC 
8325
[43]
S. aureus COL Highly methicillin resistant clinical isolate [44]
S. aureus Newman Virulent strain containing a high level of 
Clumping Factor
[45]
S. aureus RN4220 hfq RN4220, Δhfq::cat, CmR This work
S. aureus RN6390 hfq RN6390, Δhfq::cat, CmR This work
S. aureus COL hfq COL, Δhfq::cat, CmR This work
S. aureus Newman hfq Newman, Δhfq::cat, CmR This work
Plasmids
PMAD Thermosensitive plasmid in S. aureus derived 
from pRN5101 and containing the bgaB gene, 
EryR, AmpR
[38]
pMADΔhfq::cat pMAD containing up- and downstream regions 
from hfq gene cloned on either side of the Cm 
cassette (cat); used for construction of the S. 
aureus RN4220 hfq mutant, EryR, AmpR, CmR, 
bgaB
This workBMC Microbiology 2007, 7:10 http://www.biomedcentral.com/1471-2180/7/10
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DNA manipulations
Plasmid and chromosomal DNA preparations, PCR
amplifications, and DNA modifications were performed
according to commonly used techniques or suppliers'
instructions. Lysis of S. aureus cell suspensions was
achieved by treatment with 100 μg/ml of lysostaphin
(Sigma-Aldrich, St. Louis, MO, USA) for 1 hour at 37°C,
followed by standard methods for DNA preparation. DNA
transformation for E. coli [37] and for S. aureus [23] was
performed as described.
Chromosomal deletion of hfq
hfq was inactivated using the pMAD plasmid, which is
thermosensitive for replication [38], as described [23].
Briefly, regions up- and downstream of hfq were ampli-
fied, fused to flank the pC194 cat amplified gene [39] (see
primer list in Table 2) and cloned into the pGEM-T-Easy
vector (Promega, Madison, WI, USA). The segment of
interest was then subject to appropriate digestions and
cloned into pMAD. The resulting plasmid, pMAD
Δhfq::cat was introduced into the RN4220 strain and hfq
mutant derivatives were selected as described [23]. Gene
inactivation was confirmed by Southern blotting [26],
after HaeIII digestion of RN4220 WT and hfq chromo-
somal DNA, using a PCR product corresponding to the
Hfq ORF region as a probe (see Table 2 for primers used).
The hfq mutation was then transferred into RN6390, New-
man and COL S. aureus strains by ϕ11 phage-mediated
transduction [23]. Mutation transfer was confirmed by
PCR and RT-PCR (see primers list in Table 2).
RNA manipulations
Overnight cultures of staphylococcal strains in BHI
medium were diluted 1000-fold in the same medium and
grown at 37°C. Total RNAs of mid-or post- exponential or
stationary phase cultures were extracted as previously
described [40] or using the RNA spin mini Kit (GE Health-
care, Buckinghamshire, UK). Northern blot experiments
were performed using hfq, RNAIII- and spa specific frag-
ments as probes (see Table 2 for primers list), which were
α32-P labelled, as described [26]. RNA transcripts were
quantified, using hu mRNA as positive control of constitu-
tive expression. For hfq expression studies, random RT-
PCR experiments were performed using the Thermoscript
Table 2: Primers used in this study*.
Name Position Sequence Use
SA-hfq 5up (BamH1) F 5'CGGGATCCATGACGATTCT
TTAGGTGA3'
Used for cloning upstream region 
of hfq
SA-hfq 5down (KpnI) R 5'GGGGTACCTGTCGGACTCC
TTTTACT3'
SA-hfq 3up (SmaI) F 5'TCCCCCGGGATGGGCACGA
TTTAATGAC3'
Used for cloning downstream 
region of hfq
SA-hfq 3down (EcoRI) R 5'CGGAATTCTACTTGAAACAC
CTGATT
SA-cat 5 (KpnI) F 5'GGGGTACCGCACAGACAGG
ACAAAATCG
Used for cat amplification
SA-cat 3 (SmaI) R 5'TCCCCCGGGTTCCGAGGCT
CAACGTC3'
SA-hfq verif up F 5'ATCATAGCAGGTGGAACAG
3'
Used for verification of hfq 
deletion
SA-hfq verif down R 5'CGAAAGAGAAATAGAAAAA
T3'
SA-RNAIII 5 F 5'CAGAGATGTGATGGAAAAT
AGTTG3'
Used for RNA III probe 
amplification
SA-RNAIII 3 R 5'ATTAAGGGAATGTTTTACAG
TTATT3'
SA-spa 5 F 5'TTAGCATCTGCATGGTTTGC
3'
Used for spa probe amplification
SA-spa 3 R 5'ACAACGTAACGGCTTCATC
C3'
SA-hu 5 F 5'AGATTTAATCAATGCAGTTG
CAGA3'
Used for hu probe amplification
SA-hu 3 R 5'AATGCTTTACCAGCTTTG 
AATGCT3'
SA-hfq 5 (NdeI) F 5'GGAATTCCATATGATTGCAA
ACGAAAAC3'
Used for hfq probe amplification, 
RT-PCR
SA-hfq 3 (HindIII) R 5'CCCAAGCTTATTCTTCACTT
TCAGTAG3'
*F: forward; R: reverse. Restriction enzyme sites are underlined.BMC Microbiology 2007, 7:10 http://www.biomedcentral.com/1471-2180/7/10
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RT-PCR System (Invitrogen, Eugene, USA); primers used
for successive PCR are in Table 2.
Protein extract preparation, protein profile analysis and 
determinations of extra-cellular enzymatic activities
Overnight cultures of staphylococcal strains in BHI
medium were diluted 100-fold in the same medium and
grown at 37°C. Supernatant protein extracts from post-
exponential or stationary phase cultures were prepared as
described [23] and protein profiles were compared by
PAGE after staining with Coomassie blue reagent [26]. For
hemolytic or proteolytic activities, staphylococcal station-
ary phase cultures were streaked on BHI medium contain-
ing 5% rabbit, sheep, or horse blood, or on NB medium
containing 10% skimmed milk. Enzymatic halos were
compared after overnight growth at 37°C.
PM analysis
S. aureus RN6390 WT and hfq mutant strains were subject
to full profile (20 panels) PM analysis, as described else-
where [28,29,41]. This extensive analysis contains ~ 2000
tests which include utilization of different sources of car-
bon (PM1 and PM2; ~ 200 tests), nitrogen (PM3 and PM6
to PM8; ~ 400 tests) phosphorus and sulfur (PM4; ~ 100
tests), nutrient stimulation (PM5; ~ 100 tests) as well as
sensitivity to several stresses (PM9 and PM10; ~ 200 tests)
and to chemical agents that affect various biological path-
ways (PM11 to PM20; ~ 1000 tests). Detailed information
of PM experimental conditions is available [42]. Briefly,
respiration during bacterial growth under different condi-
tions is monitored by NADH production, measured with
a tetrazolium dye and evaluated for intensity of color for-
mation. Phenotypic data were recorded over a 24-hour
period. Differences in measurements of WT and hfq
mutant strains are calculated. The WT strain is recorded as
a red tracing, and the hfq mutant as a green tracing. Areas
of overlap (no changes) between the two measurements
are colored in yellow, whereas differences are colored in
red or green for WT or hfq mutant respectively. The con-
sensus profile presented is the result of two independent
comparative analyses.
To confirm some of the observations with the nitrogen
metabolic arrays (PM3 and PM6 to PM8), growth of
RN6390 WT and hfq mutant strains was compared in a
chemically defined medium [35] containing or not differ-
ent sources of nitrogen. Sensitivity to selected chemical
agents (cobalt chloride, dodine, domiphen bromide) or
antibiotics (cefotaxime) was tested by determining the
Minimum Inhibitory Concentration, (MIC) or by using
the agar disk diffusion method (Cefotaxime, Fluka). Both
of these experiments were performed in Mueller Hinton
broth.
Abbreviations
WT: Wild Type; BHI: Brain Heart Infusion; RPMI: Roswell
Park Memorial Institute; LB: Luria-Bertani; NB: Nutrient
Broth; MH: Mueller Hinton; Ery: Erythromycin; Cm:
Chloramphenicol; Amp: Ampicillin; X-Gal: 5 bromo-4-
chloro-3-indolyl-β-D-galactopyranoside; spa: Staphyloco-
ccal protein A gene; ORF: Open Reading Frame.
Authors' contributions
CB carried out the genetic and RNA experiments. CR car-
ried out the physiological and protein experiments. All
the authors contributed to analysis and interpretation of
data. CR and PB drafted the manuscript. All authors read
and approved the final manuscript.
Additional material
Acknowledgements
We thank Pascale Romby for communicating unpublished results. We are 
very grateful to Sandy Gruss for helpful discussions and critical reading of 
the manuscript. We thank Michelle David for technical assistance. We 
thank Elise Durant, Vincent Juillard and Brice Felden for helpful advice and 
discussion, and Mac Cabee for warm support. This work was supported by 
a grant "Microbiologie-Immunologie-Maladies Emergentes" from the 
"Agence Nationale pour la Recherche" (ANR). CR is the recipient of a fel-
lowship from CNRS/Conseil Général de l'Essonne.
References
1. Franze de Fer nande z MT, Eoyang L, Aug ust JT: Factor fraction
required for the synthesis of bacteriophage Qbeta-RNA.
Nature 1968, 219(154):588-590.
2. Valentin-Hansen P, Eriksen M, Udesen C: The bacterial Sm-like
protein Hfq: a key player in RNA transactions.  Mol Microbiol
2004, 51(6):1525-1533.
3. Zhang A, Wassarman KM, Rosenow C, Tjaden BC, Storz G, Gottes-
man S: Global analysis of small RNA and mRNA targets of
Hfq.  Mol Microbiol 2003, 50(4):1111-1124.
4. Muffler A, Traulsen DD, Fischer D, Lange R, Hengge-Aronis R: The
RNA-binding protein HF-I plays a global regulatory role
which is largely, but not exclusively, due to its role in expres-
sion of the sigmaS subunit of RNA polymerase in Escherichia
coli.  J Bacteriol 1997, 179(1):297-300.
5. Tsui HC, Leung HC, Winkler ME: Characterization of broadly
pleiotropic phenotypes caused by an hfq insertion mutation
in Escherichia coli K-12.  Mol Microbiol 1994, 13(1):35-49.
6. Sun X, Zhulin I, Wartell RM: Predicted structure and phyletic
distribution of the RNA-binding protein Hfq.  Nucleic Acids Res
2002, 30(17):3662-3671.
7. Ding Y, Davis BM, Waldor MK: Hfq is essential for Vibrio cholerae
virulence and downregulates sigma expression.  Mol Microbiol
2004, 53(1):345-354.
8. Robertson GT, Roop RM Jr: The Brucella abortus host factor I
(HF-I) protein contributes to stress resistance during sta-
tionary phase and is a major determinant of virulence in
mice.  Mol Microbiol 1999, 34(4):690-700.
Additional file 1
PM Analysis Results. This table indicates values of phenotypes gained or 
lost.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2180-7-10-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Microbiology 2007, 7:10 http://www.biomedcentral.com/1471-2180/7/10
Page 9 of 9
(page number not for citation purposes)
9. Nakao H, Watanabe H, Nakayama S, Takeda T: yst gene expres-
sion in Yersinia enterocolitica is positively regulated by a chro-
mosomal region that is highly homologous to Escherichia coli
host factor 1 gene (hfq).  Mol Microbiol 1995, 18(5):859-865.
10. Sonnleitner E, Hagens S, Rosenau F, Wilhelm S, Habel A, Jager KE,
Blasi U: Reduced virulence of a hfq mutant of Pseudomonas
aeruginosa O1.  Microb Pathog 2003, 35(5):217-228.
11. Figueroa-Bossi N, Lemire S, Maloriol D, Balbontin R, Casadesus J,
Bossi L: Loss of Hfq activates the sigma-dependent envelope
stress response in Salmonella enterica.  Mol Microbiol 2006.
12. Sharma AK, Payne SM: Induction of expression of hfq by DksA
is essential for Shigella flexneri virulence.  Mol Microbiol 2006,
62(2):469-479.
13. Sittka A, Pfeiffer V, Tedin K, Vogel J: The RNA chaperone Hfq is
essential for the virulence of Salmonella typhymurium.  Mol
Microbiol 2007, 63(1):193-217.
14. Christiansen JK, Larsen MH, Ingmer H, Sogaard-Andersen L, Kallipoli-
tis BH: The RNA-binding protein Hfq of Listeria monocy-
togenes: role in stress tolerance and virulence.  J Bacteriol 2004,
186(11):3355-3362.
15. Höök M, Foster TJ: Staphylococcal surface proteins.  Edited by:
Fischetti et al. Washington: ASM press; 2000. 
16. Hiramatsu K: Vancomycin-resistant Staphylococcus aureus: a
new model of antibiotic resistance.  Lancet Infect Dis 2001,
1(3):147-155.
17. Novick RP: Autoinduction and signal transduction in the reg-
ulation of staphylococcal virulence.  Mol Microbiol 2003,
48(6):1429-1449.
18. Schumacher MA, Pearson RF, Moller T, Valentin-Hansen P, Brennan
RG: Structures of the pleiotropic translational regulator Hfq
and an Hfq-RNA complex: a bacterial Sm-like protein.  EMBO
J 2002, 21(13):3546-3556.
19. Huntzinger E, Boisset S, Saveanu C, Benito Y, Geissmann T, Namane
A, Lina G, Etienne J, Ehresmann B, Ehresmann C, et al.: Staphyloco-
ccus aureus RNAIII and the endoribonuclease III coordinately
regulate spa gene expression.  EMBO J 2005, 24(4):824-835.
20. Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R,
Olson PD, Projan SJ, Dunman PM: Characterization of the Sta-
phylococcus aureus heat shock, cold shock, stringent, and
SOS responses and their effects on log-phase mRNA turno-
ver.  J Bacteriol 2006, 188(19):6739-6756.
21. Pichon C, Felden B: Small RNA genes expressed from Staphy-
lococcus aureus genomic and pathogenicity islands with spe-
cific expression among pathogenic strains.  Proc Natl Acad Sci
USA 2005, 102(40):14249-14254.
22. Roberts C, Anderson KL, Murphy E, Projan SJ, Mounts W, Hurlburt
B, Smeltzer M, Overbeek R, Disz T, Dunman PM: Characterizing
the effect of the Staphylococcus aureus virulence factor regu-
lator, SarA, on log-phase mRNA half-lives.  J Bacteriol 2006,
188(7):2593-2603.
23. Rigoulay C, Entenza JM, Halpern D, Widmer E, Moreillon P, Poquet I,
Gruss A: Comparative analysis of the roles of HtrA-like sur-
face proteases in two virulent Staphylococcus aureus strains.
Infect Immun 2005, 73(1):563-572.
24. Kajitani M, Kato A, Wada A, Inokuchi Y, Ishihama A: Regulation of
the Escherichia coli hfq gene encoding the host factor for
phage Q beta.  J Bacteriol 1994, 176(2):531-534.
25. Vytvytska O, Jakobsen JS, Balcunaite G, Andersen JS, Baccarini M, von
Gabain A: Host factor I, Hfq, binds to Escherichia coli ompA
mRNA in a growth rate-dependent fashion and regulates its
stability.  Proc Natl Acad Sci USA 1998, 95(24):14118-14123.
26. Sambrook J, Russel DW: Molecular cloning – a laboratory man-
ual.  3rd edition. Cold Spring Harbor, New York: Cold Spring Harbor
Laboratory Press; 2001. 
27. Biswas S, Biswas I: Role of HtrA in surface protein expression
and biofilm formation by Streptococcus mutans.  Infect Immun
2005, 73(10):6923-6934.
28. von Eiff C, McNamara P, Becker K, Bates D, Lei XH, Ziman M, Boch-
ner BR, Peters G, Proctor RA: Phenotype microarray profiling of
Staphylococcus aureus menD and  hemB  mutants with the
small-colony-variant phenotype.  J Bacteriol 2006,
188(2):687-693.
29. Zhou L, Lei XH, Bochner BR, Wanner BL: Phenotype microarray
analysis of Escherichia coli K-12 mutants with deletions of all
two-component systems.  J Bacteriol 2003, 185(16):4956-4972.
30. Geisinger E, Adhikari RP, Jin R, Ross HF, Novick RP: Inhibition of
rot translation by RNAIII, a key feature of agr function.  Mol
Microbiol 2006, 61(4):1038-1048.
31. Morita T, Maki K, Aiba H: RNase E-based ribonucleoprotein
complexes: mechanical basis of mRNA destabilization medi-
ated by bacterial noncoding RNAs.  Genes Dev 2005,
19(18):2176-2186.
32. Britton RA, Wen T, Schaefer L, Pellegrini O, Uicker WC, Mathy N,
Tobin C, Daou R, Szyk J, Condon C: Maturation of the 5' end of
Bacillus subtilis 16S rRNA by the esential ribonuclease YkqC/
RNase J1.  Mol Microbiol 2007, 63(1):127-138.
33. Even S, Pellegrini O, Zig L, Labas V, Vinh J, Brechemmier-Baey D, Put-
zer H: Ribonucleases J1 and J2: two novel endoribonucleases
in B. subtilis with functional homology to E. coli RNase E.
Nucleic Acids Res 2005, 33(7):2141-2152.
34. Ostberg Y, Bunikis I, Bergstrom S, Johansson J: The etiological
agent of Lyme disease, Borrelia burgdorferi, appears to con-
tain only a few small RNA molecules.  J Bacteriol 2004,
186(24):8472-8477.
35. Taylor D, Holland KT: Amino acid requirements for the growth
and production of some exocellular products of Staphyloco-
ccus aureus.  J Appl Bacteriol 1989, 66(4):319-329.
36. Lutz R, Bujard H: Independent and tight regulation of tran-
scriptional units in Escherichia coli via the LacR/O, the TetR/
O and AraC/I1-I2 regulatory elements.  Nucleic Acids Res 1997,
25(6):1203-1210.
37. Inoue H, Nojima H, Okayama H: High efficiency transformation
of Escherichia coli with plasmids.  Gene 1990, 96(1):23-28.
38. Arnaud M, Chastanet A, Debarbouille M: New vector for efficient
allelic replacement in naturally nontransformable, low-GC-
content, gram-positive bacteria.  Appl Environ Microbiol 2004,
70(11):6887-6891.
39. Horinouchi S, Weisblum B: Nucleotide sequence and functional
map of pC194, a plasmid that specifies inducible chloram-
phenicol resistance.  J Bacteriol 1982, 150(2):815-825.
40. Oh ET, So JS: A rapid method for RNA preparation from
Gram-positive bacteria.  J Microbiol Methods 2003, 52(3):395-398.
41. Bochner BR, Gadzinski P, Panomitros E: Phenotype microarrays
for high-throughput phenotypic testing and assay of gene
function.  Genome Res 2001, 11(7):1246-1255.
42. Biolog Phenotype MicroArrays   [http://www.biolog.com/]
43. Novick RP: Molecular biology of the staphylococci.  Volume 1.
New York: VCH publishers; 1990-40. 
44. Wu S, de Lencastre H, Tomasz A: Sigma-B, a putative operon
encoding alternate sigma factor of Staphylococcus aureus
RNA polymerase: molecular cloning and DNA sequencing.  J
Bacteriol 1996, 178(20):6036-6042.
45. Duthie ES, Lorenz LL: Staphylococcal coagulase; mode of
action and antigenicity.  J Gen Microbiol 1952, 6(1–2):95-107.